Authors


Natalie Pompilio

Latest:

OCM Practices Struggle with CMS Report Cards

When the CMS released performance reports for the 181 practices enrolled in the Oncology Care Model (OCM) earlier this year, the action had the effect of creating as much confusion as it resolved.


Yvette C. Terrie, BSPharm, RPh

Latest:

Pharmacists Can Advise Patients With Androgenetic Alopecia

Pharmacists play a role in advising patients with hair loss about self-management and proper application of over the counter products.


Aruna Kamineni, PhD

Latest:

Comorbidities and Cardiovascular Disease Risk in Older Breast Cancer Survivors

Effective management of the comorbidities of diabetes and hypertension may increase survival in older breast cancer survivors.




Yu-Hsiang Kao, PhD

Latest:

Continuity of Outpatient Care and Avoidable Hospitalization: A Systematic Review

Higher continuity of care was statistically significant and was associated with fewer ambulatory care–sensitive condition hospitalizations.



Maureen Hennessey, PhD, CPCC, CPHQ

Latest:

Contributor: Patient-Centered Approaches to Supporting Medication Adherence Among Persons With Schizophrenia

There are effective strategies that can be employed concurrently to promote adherence to medications for schizophrenia, including but not limited to pharmacological, technological, and psychosocial interventions.


Martin Slade, MPH

Latest:

Process of Care Compliance Is Associated With Fewer Diabetes Complications

Adherence to process of care measures was associated with reduced risk of 2 diabetes complications or any of 4 complications in a national industrial cohort.


Steven D. Nathan, MD

Latest:

Unmet Needs in IPF- and ILD-Related Pulmonary Hypertension and Emerging Therapy for IPF

Steven Nathan, MD, discusses additional noteworthy data from CHEST 2024 on emerging therapies for IPF and PAH and highlights his excitement for ongoing research focused on improving early detection, personalized treatments, and improving long-term patient outcomes.


Peter G. Szilagyi, MD, MPH

Latest:

Managed Care Quality and Disenrollment in New York SCHIP

Using data from the New York SCHIP program, this study showed that plan disenrollment was not significantly associated with managed care plan quality.



Rose M. Kakoza, MD, MPH

Latest:

ED-Based Care Coordination Reduces Costs for Frequent ED Users

Results of our pilot randomized controlled intervention involving emergency department (ED)-based care coordination and community health workers demonstrated a trend toward fewer ED visits, fewer hospitalizations, and lower costs among intervention patients.


Brendan Rabideau, BA

Latest:

Impact of Consumer-Directed Health Plans on Low-Value Healthcare

Switching to a consumer-directed health plan is associated with reduced overall outpatient spending, but not with reduced spending on low-value healthcare services.





Elan Feldhamer, BA

Latest:

Disparities in Antidepressant Adherence in Primary Care: Report From Israel

Patient characteristics such as psychiatric diagnosis were associated with variations in adherence, although physician characteristics were not.



Kurt Ullman

Latest:

Bundled Payment: Practice Savior or Killer?

As payment reform models continue to evolve, practitioners must determine which strategy makes the most sense for their practice. Although the idea behind bundled payments may be worth considering, there are some concerns that this system could causes disruptions in oncology practices.


Margaret R. Stedman, MPH

Latest:

Adherence to Osteoporosis Medications After Patient and Physician Brief Education: Post Hoc Analysis of a Randomized Controlled Trial

Post hoc analysis of a randomized controlled trial found that a 1-session educational intervention targeted at patients and primary care physicians did not improve osteoporosis medication adherence.


Jason Lones, BA

Latest:

Postdischarge Telephone Calls by Hospitalists as a Transitional Care Strategy

Treating hospitalists effectively identify and efficiently address early postdischarge problems through a single, brief telephone encounter.




Ingrid Marino, MS, CGC

Latest:

Precision Oncology: Why Payers Should Initiate CGP Coverage Now!

Precision oncology, or the clinically and financially efficient use of genomically matched treatments and clinical trials, is evolving as a potentially important starting point for cancer care within successful alternative payment models.


David Sharp, PhD

Latest:

Patient-Centered Teamwork in Care Transitions

Physician-led patient care teams have the potential to impact care transitions to prevent fragmentation of care, and ensure seamless care delivery.




Nathan W. Carroll, MHA

Latest:

Costs of Providing Antiplatelet Medication for Percutaneous Coronary Intervention Patients

An insurance benefit that provides percutaneous coronary intervention patients with a discharge supply of antiplatelet medication could result in cost savings for insurers.


Timothy L. Vollmer, MD

Latest:

Comparative Effectiveness of Early Natalizumab Treatment in JC Virus-Negative Relapsing-Remitting Multiple Sclerosis

We estimated the long-term risks and benefits of disease modifying therapies. Benefits were favored by natalizumab with minimal increased risks in the negative anti-JC virus population.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo